PubMed · 8141715
Issues raised by GUSTO.
Abstract
The GUSTO trial raises several questions including the role of heparin in thrombolysis. The need for intravenous versus subcutaneous heparin with streptokinase (SK) has not been clarified in this trial. It is more likely that the superiority of tissue plasminogen activator (t-PA) was due to its accelerated administration rather than the accompanying heparin. Despite the improvement in survival, much is still to be achieved in obtaining optimal reperfusion rates.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
H White. 1993. Issues raised by GUSTO.. https://doi.org/10.1111/j.1445-5994.1993.tb04752.x
Cite the original work for its findings. Save a collection to share your selection of sources.